Showing 16,181 - 16,200 results of 17,628 for search '"progress"', query time: 0.11s Refine Results
  1. 16181

    RETRACTED ARTICLE: Single-cell omics and machine learning integration to develop a polyamine metabolism-based risk score model in breast cancer patients by Xiliang Zhang, Hanjie Guo, Xiaolong Li, Wei Tao, Xiaoqing Ma, Yuxing Zhang, Weidong Xiao

    Published 2024-10-01
    “…The metabolic pathway of polyamines is crucial in breast cancer progression, with a strong association to the increased capabilities of tumor cells for proliferation, invasion, and metastasis. …”
    Get full text
    Article
  2. 16182

    Osteoarthritis of the knee joint and its association with metabolic syndrome: A case control study by Rohini Motwani, Arvind Kumar Bodla, Shravan Kumar Peddamadyam, Mrudula Chandrupatla, Nagesh Cherukuri, Maheshwar Lakkireddy, Gunvanti Rathod, Sai Ram Challa, Chowdavarapu Raghavendra Rao, Abhishek Arora, Srikanth Eppakayala, Arcot Reddy Vamsi Krishna

    Published 2025-01-01
    “…While evidence suggests that MetS and its components may influence the development of osteoarthritis (OA), the specific relationship between MetS and the likelihood of progressing to a stage of OAK that requires Total knee replacement (TKA) remains underexplored. …”
    Get full text
    Article
  3. 16183

    Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers by Jintao Ma, Xiaohong Xu, Wenhan Huang, Yong Hu, Gang Chen, Jian He

    Published 2025-01-01
    “…Cancer-specific survival (CSS) and progression-free survival (PFS) were assessed using Kaplan-Meier analysis and log-rank tests. …”
    Get full text
    Article
  4. 16184

    MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancer by Hongmei Zheng, Songqing Fan, Jiadi Luo, Qiuyuan Wen, Hongjing Zang

    Published 2025-01-01
    “…Abstract MicroRNA (miRNA) dysregulation has been identified in several carcinomas, including non-small cell lung cancer (NSCLC), and is known to play a role in the development and progression of this disease. We initially conducted a miRNA microarray analysis, which revealed that the MNK inhibitor CGP57380 increased the expression of miR-150-3p. …”
    Get full text
    Article
  5. 16185

    Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study by Bin Yin, Wei Luo

    Published 2025-01-01
    “…Results Objective response rate (52.2% vs. 35.4%), disease control rate (91.3% vs. 81.3%), surgical resection rate (95.7% vs. 85.4%), R0 resection rate (87.0% vs. 75.0%), and the proportion of patients with tumor regression grade 0–1 (31.8% vs. 17.1%) tended to increase in bevacizumab plus chemo group versus chemo group, although there was no statistical significance. The 48-month progression-free survival (PFS) rates were 58.3% and 33.4% in bevacizumab plus chemo group and chemo group. …”
    Get full text
    Article
  6. 16186

    PHARC syndrome: an overview by Lusine Harutyunyan, Patrick Callaerts, Sascha Vermeer

    Published 2024-11-01
    “…Abstract PHARC, polyneuropathy, hearing loss, cerebellar ataxia, retinitis pigmentosa and cataracts, or PHARC is a very rare progressive neurodegenerative autosomal recessive disease caused by biallelic mutations in the ABHD12 (a/b-hydrolase domain containing 12) gene, which encodes a lyso-phosphatidylserine (lyso-PS) lipase. …”
    Get full text
    Article
  7. 16187

    Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors by Xue Han, Francis Lobo, Michael S. Broder, Eunice Chang, Sarah N. Gibbs, David J. Ridley, Irina Yermilov

    Published 2021-05-01
    “…In adjusted analyses, abatacept patients had a lower risk of discontinuing index treatment due to disease progression (0.3 \[95% confidence interval (CI): 0.1-0.6\], *P*=0.001). …”
    Get full text
    Article
  8. 16188

    Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated... by Yoko Harima, Takuro Ariga, Yuko Kaneyasu, Hitoshi Ikushima, Sunao Tokumaru, Shigetoshi Shimamoto, Takeo Takahashi, Noriko Ii, Kayoko Tsujino, Anneyuko I Saito, Hiroki Ushijima, Takafumi Toita, Tatsuya Ohno

    Published 2021-01-01
    “…In this multicenter prospective cohort study, the usefulness of pre- and posttreatment serum protein levels of potential biomarkers, including squamous cell carcinoma antigen (SCC-Ag), apolipoprotein C-II (ApoC-II), matrix metalloproteinase (MMP)1, and MMP2, were evaluated together with clinical factors in 145 cervical cancer patients in order to determine their suitability to predict survival. Progression-free survival (PFS) was the primary endpoint, and overall survival (OS), pelvic PFS (PPFS), and distant metastasis-free survival (DMFS) were the secondary endpoints. …”
    Get full text
    Article
  9. 16189

    Effects of Resistant Starch on Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis by Xinyi Du, Jing Wu, Chenlin Gao, Qinqin Tan, Yong Xu

    Published 2022-01-01
    “…Recent studies shown that the progression of CKD may be related to the change of intestinal flora. …”
    Get full text
    Article
  10. 16190

    Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better by Ming Zheng

    Published 2022-01-01
    “…ICB treatment outcomes were analyzed by overall survival, progression-free survival and objective response rate.Results No universally valid TMB cut-off was available for all cancer types. …”
    Get full text
    Article
  11. 16191

    High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma by Haopeng Wen, Tengfei Ji, Liteng Lin, Nan Cheng, Kangshun Zhu, Liangqi Cao

    Published 2023-01-01
    “…Our study suggested TET1 as a potential indicator in HCC progression. TET1 was closely involved in immune infiltration and activation of oncogenic pathways. …”
    Get full text
    Article
  12. 16192

    Reperfusion injury or cytokine storm? Utilizing plasmapheresis in severe trauma-induced multiorgan failure: a case report by Gun Woo Kim, Suyeong Hwang, Kyoung Hoon Lim, Sung Hoon Cho

    Published 2024-12-01
    “…However, plasmapheresis may represent an effective treatment option in cases of severe progression.…”
    Get full text
    Article
  13. 16193

    Civil servants' activity regulation in Lithuania 1918-1940 by Jolanta Palidauskaitė, Milda Petrokaitė

    Published 2010-06-01
    “…Public discussion and ideas of scholars were rather modern, progressive, and reminded ideas of famous authorities of management. …”
    Get full text
    Article
  14. 16194

    Plasma-derived extracellular vesicles prime alveolar macrophages for autophagy and ferroptosis in sepsis-induced acute lung injury by Rongzong Ye, Yating Wei, Jingwen Li, Yu Zhong, Xiukai Chen, Chaoqian Li

    Published 2025-02-01
    “…These findings suggest a novel mechanism of plasma-AM interaction in sepsis-induced ALI, offering a plausible strategy for assessing septic progression and treating lung injury.…”
    Get full text
    Article
  15. 16195

    Immunohistochemical expression of parathyroid hormone-related protein and ezrin in invasive breast carcinoma of no special type: a retrospective analysis by Menna Allah Gamil Ali Shalaby, Marwa Mohammed Dawoud, Marwa Salah Gadallah, Asmaa Gaber Abdou

    Published 2025-01-01
    “…Conclusion The study highlights the significant roles of PTHrP and ezrin in breast cancer progression. Elevated levels of these proteins are associated with more aggressive disease, suggesting their capability as prognostic indicators and treatment targets in breast cancer. …”
    Get full text
    Article
  16. 16196

    Association of Fatty Acid Synthase with Level of Fatty Acids in Osteoporosis Patients by Abeer Hassan Alwan, Ekhlass M. Taha

    Published 2025-01-01
    “…In conclusion, the parameters of FAS, HDL, VLDL, TG, TAS, and TOS were effective in monitoring the progression of osteoporosis, as well as fatty acid level. …”
    Get full text
    Article
  17. 16197

    La bibliothèque dans Buffy contre les vampires : grimoires et merveilles by Vanessa Bertho

    Published 2010-01-01
    “…Elle s’avère incontournable pour la progression dramatique de la diégèse et l’installation des systèmes de représentation mythologiques. …”
    Get full text
    Article
  18. 16198

    Numerical Analysis on the Load Sharing Performance of Long-Short CFG Pile Composite Foundation Subjected to Rotation of Adjacent Retaining Wall by Bantayehu Uba Uge, Yuancheng Guo, Yunlong Liu

    Published 2021-01-01
    “…It is revealed that to arrive at a new static equilibrium during progression of wall rotation, the percentage load sharing ratios of the long and short piles change increasingly while the load proportion carried by the upper soil reduces remarkably. …”
    Get full text
    Article
  19. 16199

    Does water quality matter? Foraging activity of Daubenton’s bat (Myotis daubentonii) over three lakes with different trophy by Małgorzata Strzałka, Katarzyna Kozakiewicz, Postawa Tomasz

    Published 2024-12-01
    “…Hence, the observed slow increase in the number of M. daubentonii over the past 20 years cannot be attributed to, as previously suggested, eutrophication, but, on the contrary, seems to be a result of a progressive improvement in the environment. …”
    Get full text
    Article
  20. 16200

    Clinical features, pathological characteristics, and prognosis of patients with IgA nephropathy complicated with nephrotic syndrome by Li Tan, Lu-Hua Jin, Yi-Qin Wang, Wei Chen, Qiong Wen

    Published 2025-01-01
    “…Renal endpoint was defined as a 50% decrease in estimated glomerular filtration rate or progression to end-stage renal disease. A total of 207 patients with IgAN and NS were categorized into four pathological groups: IgAN with mesangial proliferative glomerulonephritis (IgAN-MsPGN) (n = 150), IgAN with minimal change disease (IgAN-MCD) (n = 49), IgAN with membranous nephropathy (IgAN-MN) (n = 7), and IgAN with membranoproliferative glomerulonephritis (IgAN-MPGN) (n = 1). …”
    Get full text
    Article